EUVIMEDEUVIMED entdecken
Crossref

Identification of Epigallocatechin‐3‐O‐p‐coumaroate as a Multi‐Target Inhibitor of Key Thyroid Proteins: An Integrated In‐Silico, DFT, and Molecular Dynamics Study

Kainat Shahid, Muhammad Ali, Rana Muhammad Mateen, Inshal Aamer, Muhammad Tahir Mushtaq, Rafaqat Hussain, Inam Ur Rahman, Metab Alharbi

ChemistrySelect · 2026-11 · 11 (44)

DOI: 10.1002/slct.75193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 18.11.2026. Verfasst von Kainat Shahid und 7 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Gefördert von: King Saud University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid disorders are among the most prevalent endocrine condition, highlighting the need for safer therapeutic candidates. This study screened plant derived secondary metabolites against four thyroid related targets, Thyroid Peroxidase (TPO; PDF 5MFA used as a structural surrogate), Sodium‐Iodide Symporter (NIS), Thyroid‐Stimulating Hormone Receptor (TSHR), and Transforming Growth Factor‐beta (TGF‐β). A library of 3000 phytochemicals from 11 medicinal plant families were screened using Swiss ADME and PreADMET, yielding 220 candidates for molecular docking with AutoDock Vina. Methimazole, perchlorate, and SB‐431542 served as reference compounds where applicable. Epigallocatechin‐3‐O‐p‐coumaroate emerged as the leading multi‐target candidate, demonstrating favorable binding across all four proteins and outperforming the corresponding reference compounds. Density functional theory analysis indicated favorable electronic reactivity and stability, characterized by a narrow HOMO–LUMO energy gap. ProTox‐3.0 predicted a favorable safety and non‐cytotoxic profile. Furthermore, a 100‐ns molecular dynamics simulation of the TGF‐β complex supported stable pocket occupancy and persistent intermolecular interactions. Overall, Epigallocatechin‐3‐O‐p‐coumaroate represents a promising natural multi‐target lead compound for modulating four key thyroid proteins. This may provide a strong computational foundation for future in vitro and in vivo experimental validation.

Förderung

  • King Saud University

Zitieren

APA

Shahid, K., Ali, M., Mateen, R. M., Aamer, I., Mushtaq, M. T., Hussain, R., Rahman, I. U., & Alharbi, M. (2026). Identification of Epigallocatechin‐3‐O‐p‐coumaroate as a Multi‐Target Inhibitor of Key Thyroid Proteins: An Integrated In‐Silico, DFT, and Molecular Dynamics Study. ChemistrySelect, 11(44). https://doi.org/10.1002/slct.75193

Vancouver

Shahid K, Ali M, Mateen RM, Aamer I, Mushtaq MT, Hussain R, et al. Identification of Epigallocatechin‐3‐O‐p‐coumaroate as a Multi‐Target Inhibitor of Key Thyroid Proteins: An Integrated In‐Silico, DFT, and Molecular Dynamics Study. ChemistrySelect. 2026;11(44). doi:10.1002/slct.75193

BibTeX
@article{Shahid2026,
  author = {Shahid, Kainat and Ali, Muhammad and Mateen, Rana Muhammad and Aamer, Inshal and Mushtaq, Muhammad Tahir and Hussain, Rafaqat and Rahman, Inam Ur and Alharbi, Metab},
  title = {Identification of Epigallocatechin‐3‐O‐p‐coumaroate as a Multi‐Target Inhibitor of Key Thyroid Proteins: An Integrated In‐Silico, DFT, and Molecular Dynamics Study},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {44},
  doi = {10.1002/slct.75193}
}
Kostenlos starten →